Information about Celgene Netherlands Investment
My details
*
*
*

Celgene Netherlands Investment (SRL)

30286393

Orteliuslaan 1000, 3528 BD Utrecht

Company information

Status
Active

KVK number

30286393

VAT Number

Established
07-04-2010
Last balance sheet year
2024
Company size
Small 0 FTE
RSIN number
822296731
Principal activity
Activiteiten van financieringsentiteiten binnen concernverband
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Celgene Netherlands Investment

2024 2023 2022 2021
Equity € 2.266.697 3 % € 2.195.846 3 % € 2.123.761 0 % € 2.130.345
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Celgene Netherlands Investment?
The KVK number of Celgene Netherlands Investment is 30286393
What is the VAT number of Celgene Netherlands Investment?
Log in or start a free trial to view the VAT number.
Wat is the PEPPOL ID of Celgene Netherlands Investment?
There is no information available about the PEPPOL ID of Celgene Netherlands Investment or the company is not yet registered on the PEPPOL network.
When was Celgene Netherlands Investment founded?
Celgene Netherlands Investment was founded on 07-04-2010.
What is the address of Celgene Netherlands Investment?
The current registered office of Celgene Netherlands Investment is located at Orteliuslaan 1000, 3528 BD Utrecht.
When was the last time Celgene Netherlands Investment filed their annual financial statements?
The most recent financial statements of Celgene Netherlands Investment were filed on 31-12-2024.
How many employees does Celgene Netherlands Investment have?
There are currently no employees working at Celgene Netherlands Investment or no workforce information is available.
What is the annual turnover of Celgene Netherlands Investment?
There is no turnover available for Celgene Netherlands Investment.

Sources